ipilimumab,nivolumab
bms
['niche-2']
ah..
the end to a lovely day. #esmo22 highlights on neoadjuvant ici in locally advanced dmmr colon cancer: the niche-2 study 
volunteer #CRCSM librarian
#BRAF & #NRAS FB grps
Stage 4 CRC Support & Colon Cancer Stars
trials Stage 2/3 pts
https://t.co/48vU5493pH